logo
Elusive, endangered predator spotted on trail camera in Chile, photos show

Elusive, endangered predator spotted on trail camera in Chile, photos show

Miami Herald2 days ago

An elusive and endangered predator was recently spotted in Chile, delighting conservation officials.
The creature — known as a Darwin's fox — was recorded by a camera trap in the Cutipay Wetland Nature Sanctuary, about 500 miles south of Santiago, according to a May 22 news release from the Ministry of Environment.
While reviewing footage from the camera in April, officials noticed three images, dated to Dec. 30, that showed a dark-colored animal trudging through the undergrowth.
After officials consulted with experts, it was confirmed to be a Darwin's fox, described as a one-of-a-kind and notoriously hard to spot inhabitant of the South American nation.
Iconic and elusive species
Distinguished by its dark fur, pointed ears and solitary behavior, the animal has intrigued scientists for generations.
The vulpine creature was first described by Charles Darwin in 1834 on Chile's Chiloé Island. According to his notes, he noticed a fox sitting on rocks near the shore, observing nearby officers.
'I was able, by quietly walking up behind, to knock him on the head with my geological hammer,' the famous naturalist wrote, according to The Lancet. The specimen was later displayed in a museum.
But, in the decades that followed, the animal was believed to be a subspecies of the South American gray fox. It wasn't until 1996 — after biologists studied its DNA — that Darwin's fox was determined to be its own distinct species, according to The New York Times.
Nowadays, it is classified as endangered by the International Union for Conservation of Nature.
And, the vast majority of the species' population is believed to live on Chiloé, where Darwin encountered his specimen. The populations on the mainland are significantly smaller and more dispersed.
But, the recent sighting in Cutipay — a poorly studied region — expands the species' territory. In fact, the area could play a pivotal role in connecting various populations and facilitating the species' movement, officials said.
Environment Minister Maisa Rojas applauded the discovery, saying it shows the importance of conservation policies.
That said, the recent images of the fox also bring to light new threats that the species could face in the area.
The primary threat is the existence of domestic dogs, which could attack the endangered foxes and potentially transmit diseases. Invasive animals — such as mink — as well as deforestation, forest fires and unregulated construction could also negatively impact the species.
With this in mind, Alberto Tacon, a regional environmental official, emphasized the need to protect the forests in Cutipay and the animals that inhabit them.
Google Translate was used to translate a news release from the Chilean Ministry of Environment.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Chilean scientists develop probiotic to help prevent stomach cancer
Chilean scientists develop probiotic to help prevent stomach cancer

UPI

timean hour ago

  • UPI

Chilean scientists develop probiotic to help prevent stomach cancer

Chilean scientists develop the world's first patented probiotic shown to prevent gastric cancer. File Photo by Billie Jean Shaw/UPI May 30 (UPI) -- Scientists at the University of Concepción in Chile have developed the world's first patented probiotic designed to prevent gastric cancer. The oral supplement is 93.6% effective and targets Helicobacter pylori, a key bacterial factor in the disease. The probiotic forms a protective coating along the stomach lining, preventing the bacteria from attaching when contaminated food or water is consumed. The supplement is approved for use starting at age 8 and also functions as an immunobiotic, helping regulate the body's immune response. Chilean biochemist and Ph.D. in biological sciences Apolinaria García led the research, using Lactobacillus fermentum as the base of the probiotic compound. Gastric cancer is among the most common cancers worldwide and ranks as the fourth-deadliest. Often called a "silent killer," its early symptoms are difficult to distinguish from more common and benign digestive conditions. Helicobacter pylori is found in about half the global population and is linked not only to gastric cancer but also to precursor conditions such as stomach ulcers and MALT lymphoma. In the United States, the American Cancer Society estimates that nearly 30,000 new stomach cancer cases will be diagnosed in 2025, with more than 10,000 deaths expected. In Latin America, countries such as Chile, Peru, Ecuador and Colombia report some of the highest incidence rates and lowest survival rates for gastric cancer, said Dr. Patricio Mardónez, president of Chile's National Health Network. He noted that countries like Japan and South Korea have significantly reduced mortality through widespread early detection and screening programs. "Regionally, what was once a cancer seen mostly in people over 65 is now being detected in patients under 50," Mardónez said. While the exact causes behind the rise in gastric cancer diagnoses among younger people are still under investigation, several hypotheses have been proposed. Changes in diet and lifestyle may be contributing, including increased consumption of highly processed foods high in sodium and low in fresh fruits and vegetables. Sedentary behavior and obesity are also risk factors, along with prolonged use of medications such as proton pump inhibitors (PPI), commonly prescribed for acid reflux.

Robert Jarvik, who co-designed the first permanent artificial heart, dies at 79
Robert Jarvik, who co-designed the first permanent artificial heart, dies at 79

Yahoo

timean hour ago

  • Yahoo

Robert Jarvik, who co-designed the first permanent artificial heart, dies at 79

Dr. Robert Jarvik, who was a key designer of the first permanent artificial heart implanted in a human, died on Monday in his Manhattan home at age 79. Jarvik received his medical degree at the University of Utah, and the implant of the first permanent artificial heart took place at the school as well. The surgery became the subject of both public fascination and fierce debate over medical ethics. According to The New York Times, Jarvik's wife, Marilyn vos Savant, said his cause of death was complications from Parkinson's disease. Jarvik was born in Midland, Michigan on May 11, 1946, and grew up in Stamford, Connecticut. His father, Norman, was a physician who ran a family practice and his mother Edythe ran scheduling at the practice, according to The New York Times. Growing up, he was a 'tinkerer' who planned to study architecture but turned his interest to medicine after his father survived an aortic aneurysm, the Times obitury said. Norman Jarvik later died of a second aortic aneurysm. Jarvik attended Syracuse University before studying medicine for two years at Italy's University of Bologna. Jarvik received a master's degree in occupational biomechanics from New York University and then moved to the University of Utah in 1971 where he completed a medical degree in 1976. Jarvik did not follow the traditional medical career path of internship and residency, because he was more interested in developing an artificial heart, per The New York Times. He married Vos Savant in 1985, who survives him. Jarvik had two children, Kate Jarvik Birch and Tyler Jarvik, from his marriage to playwright and former Deseret News journalist Elaine Levin Jarvik, to whom he was married from 1968 to 1985. Vos Savant also has two children from a previous relationship, Mary Blinder and Dennis Younglove. Jarvik had five grandchildren. Jarvik was on a team that worked with Dr. Willem Kolff, the director of the university's Division of Artificial Organs, to design a series of mechanical hearts. One of them, in 1982, was implanted in a cow named Alfred Lord Tennyson, who survived for 268 days, setting a record for an animal. It was in 1982 that the U.S. Food and Drug Administration gave permission to the University of Utah to implant a permanent artificial heart in a human. On Dec. 2, 1982, Dr. William C. DeVries led the surgical team that implanted the Jarvik-7 model in Barney Clark, a 61-year-old retired dentist. To encourage excellent work, Kolff put a student's name on a version of the heart to which they'd made a significant alteration, which is how the heart became the Jarvik-7, as Deseret News reported. The surgery to implant the Jarvik-7, made of aluminum and plastic, lasted seven hours and afterwards Clark told his wife, 'I want to tell you even though I have no heart, I still love you,' per the University of Utah. Clark survived 112 days attached to a 400-pound air compressor — roughly the size of a dishwasher — which helped the Jarvik-7 pump blood through his body. He never left the hospital and the complications included seizures, kidney failure and a broken valve on the artificial heart. Clark died on March 23, 1983, of complications of a bacterial infection of the colon. The second and third patient lived 620 days and 488 days, respectively, after receiving the experimental heart. According to The New York Times, their survival showed that people 'could live long term on the plastic and metal device,' but that the complications the recipients suffered 'impaired the quality of their lives and blunted initial enthusiasm for the heart.' Reporters from all over flocked to University of Utah hospital to cover the artificial heart. The news was celebrated by some, criticized by others. 'By the mid-1980s, medical ethicists and theologians were debating whether artificial hearts improved life or extended a painful decline toward death,' per The New York Times. The Jarvik-7 was implanted in five patients as a permanent artificial heart and used hundreds of times as a temporary implant as patients waited for a donor heart. The FDA withdrew approval in 1990. In 2018, Jarvik was honored by United Business Media for Lifetime Achievement, according to The University of Utah. After leading Symbion, Inc., which was based in Salt Lake City, Jarvik founded Jarvik Heart, Inc. in 1987, based in New York. The company developed smaller, less obtrusive ventricular assist devices that helped pump blood from the heart's lower chambers to the rest of the body. The Jarvik 2000 is around the size of a C battery and its pediatric version, the Jarvik 2015, is about the size of a AA battery, per The New York Times.

RFK Jr. may stop government scientists from publishing in top journals
RFK Jr. may stop government scientists from publishing in top journals

Yahoo

timea day ago

  • Yahoo

RFK Jr. may stop government scientists from publishing in top journals

May 29 (UPI) -- U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he may no longer allow government scientists to publish research in top medical journals. Kennedy made the statement on a podcast called The Ultimate Human, on which he called the journals "corrupt" and said they were controlled by drug companies. "We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA and those other journals," Kennedy said. All three journals are known for publishing peer-reviewed studies and are widely read by health professionals around the world. JAMA and The Lancet each get more than 30 million visits to their websites every year. The New England Journal of Medicine reaches more than 1 million readers weekly, in print and online, The Washington Post reported. None of the journals responded right away to Kennedy's comments. Kennedy said he wants HHS to create its own journals instead. They would "become the preeminent journals, because if you get [NIH] funding, it is anointing you as a good, legitimate scientist." But some public health experts strongly disagreed. "Banning NIH-funded researchers from publishing in leading medical journals and requiring them to publish only in journals that carry the RFK Jr. seal of approval would delegitimize taxpayer-funded research," Dr. Adam Gaffney, an assistant professor at Harvard Medical School, told The Post. Gaffney also warned that drug approvals rely on science. While saying it's important to guard against commercial interests, he warned that Kennedy's plans - along with funding cuts and anti-vaccine views - could hurt public health. On the podcast, Kennedy also criticized government agencies under HHS, including the U.S. Centers for Disease Control and Prevention, U.S. Food and Drug Administration, National Institutes of Health and Medicare and Medicaid offices. He described them as "sock puppets" for the pharmaceutical industry. The podcast came out shortly after Kennedy announced his department would stop recommending the COVID-19 vaccine for healthy children and pregnant women, bypassing CDC guidance. Last week, the administration also released a new "Make America Health Again" report that challenged common views in medicine, including on vaccines. The Post said the report included misleading information and claims not backed by strong evidence. In April, a U.S. attorney sent a rare letter to the journal Chest, questioning its editorial policies. Critics said the move threatened freedom of speech, The Post reported. Meanwhile, NIH funding has dropped by more than $3 billion since January, and many top universities are losing out on funding for research. Kennedy has also led a major staff reduction at HHS, with about 20,000 federal workers cut - affecting almost every part of the agency, The Post said. The cuts and funding freezes have led some U.S. scientists to consider leaving the country for jobs elsewhere. Countries like France, Germany, Spain and China are now actively recruiting American researchers. More information The Annals of the Royal College of Surgeons of England has more about the role of journals. Copyright © 2025 HealthDay. All rights reserved.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store